eCite Digital Repository

Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry

Citation

Jo, HE and Glaspole, I and Moodley, Y and Chapman, S and Ellis, S and Goh, N and Hopkins, P and Keir, G and Mahar, A and Cooper, W and Reynolds, P and Haydn Walters, E and Zappala, C and Grainge, C and Allan, H and Macansh, S and Corte, TJ, Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry, BMC Pulmonary Medicine, 18, (1) Article 19. ISSN 1471-2466 (2018) [Refereed Article]


Preview
PDF
564Kb
  

Copyright Statement

Copyright 2018 the authors. Licensed under Creative Commons Attribution 4.0 International (CC BY 4.0) https://creativecommons.org/licenses/by/4.0/

DOI: doi:10.1186/s12890-018-0575-y

Abstract

Background: Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal fibrosing lung disease of unknown cause. The advent of anti-fibrotic medications known to slow disease progression has revolutionised IPF management in recent years. However, little is known about the natural history of IPF patients with mild physiological impairment. We aimed to assess the natural history of these patients using data from the Australian IPF Registry (AIPFR).

Methods: Using our cohort of real-world IPF patients, we compared FVC criteria for mild physiological impairment (FVC ≥ 80%) against other proposed criteria: DLco ≥ 55%; CPI ≤40 and GAP stage 1 with regards agreement in classification and relationship with disease outcomes. Within the mild cohort (FVC ≥ 80%), we also explored markers associated with poorer prognosis at 12 months.

Results: Of the 416 AIPFR patients (mean age 70.4 years, 70% male), 216 (52%) were classified as 'mild' using FVC ≥ 80%. There was only modest agreement between FVC and DLco (k = 0.30), with better agreement with GAP (k = 0.50) and CPI (k = 0.48). Patients who were mild had longer survival, regardless of how mild physiologic impairment was defined. There was, however, no difference in the annual decline in FVC% predicted between mild and moderate-severe groups (for all proposed criteria). For patients with mild impairment (n = 216, FVC ≥ 80%), the strongest predictor of outcomes at 12 months was oxygen desaturation on a 6 min walk test.

Conclusion: IPF patients with mild physiological impairment have better survival than patients with moderate-severe disease. Their overall rate of disease progression however, is comparable, suggesting that they are simply at different points in the natural history of IPF disease.

Item Details

Item Type:Refereed Article
Keywords:idiopathic pulmonary fibrosis, interstitial lung disease, disease severity
Research Division:Medical and Health Sciences
Research Group:Cardiorespiratory Medicine and Haematology
Research Field:Respiratory Diseases
Objective Division:Health
Objective Group:Clinical Health (Organs, Diseases and Abnormal Conditions)
Objective Field:Respiratory System and Diseases (incl. Asthma)
UTAS Author:Haydn Walters, E (Professor Haydn Walters)
ID Code:131284
Year Published:2018
Web of Science® Times Cited:10
Deposited By:Medicine
Deposited On:2019-03-12
Last Modified:2019-04-08
Downloads:4 View Download Statistics

Repository Staff Only: item control page